Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.

Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.

Item
http://www.wikidata.org/entity/Q27852121
CIViC databaseFunctional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly.The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathwaysElovl6 is a poor prognostic predictor in breast cancer.IDENTIFYING CANCER SPECIFIC METABOLIC SIGNATURES USING CONSTRAINT-BASED MODELS.miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis.Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation.Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.The thermo-sensitive gene expression signatures of spermatogenesis.Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer
P2860

Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.

Item
http://www.wikidata.org/entity/Q27852121
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@ast
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@en
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@nl
type
label
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@ast
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@en
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@nl
prefLabel
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@ast
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@en
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Inhibition of ATP citrate lyas ...... marker for therapeutic impact.
@en
P2093
P304
P31
P3181
P356
10.1016/J.AJPATH.2013.01.048
P407
P433
P478
P50
P577
P5875
P698
P921